Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformation
Preprint
Abstract
M pro is of considerable interest as a drug target in the treatment of COVID-19 since the proteolytic activity of this viral protease is essential for viral replication. Here we report the first insight of the structure M pro for SARS-CoV-2 in the inactive conformation under conditions close to the physiological state (pH 7.5) to an overall resolution of 1.9 Å. The comparisons of M pro in different states reveal that substrate binding site and the active site are more flexible in the inactive conformation than that in the active conformations. Notably, compared with the active conformation of the apo state structure in pH7.6 of SARS, the SARS-CoV-2 apo state is in the inactive conformation under condition close to physiological state (pH7.5). Two water molecules are present in the oxyanion hole in our apo state structure, whereas in the ligand-bound structure, water molecular is absence in the same region. This structure provides novel and important insights that have broad implications for understanding the structural basis underlying enzyme activity, and can facilitate rational, structure-based, approaches for the design of specific SARS-CoV-2 ligands as new therapeutic agents.Keywords
This publication has 9 references indexed in Scilit:
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main proteaseScience, 2020
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofurNature Structural & Molecular Biology, 2020
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug CarmofurbioRxiv, 2020
- Structure of M pro from COVID-19 virus and discovery of its inhibitorsbioRxiv, 2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Coronaviruses — drug discovery and therapeutic optionsNature Reviews Drug Discovery, 2016
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug designThe FEBS Journal, 2014
- The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitorProceedings of the National Academy of Sciences, 2003
- Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domainThe EMBO Journal, 2002